Allied Capital Corp (AFC) 26.02 $AFC Lessons From A

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Allied Capital Corp (AFC) 26.02 $AFC

Lessons From A Dozen Years Of Short Selling
Whitney Tilson - Seeking Alpha - Fri Feb 27, 9:39AM CST
(Editor's Note: Long-time contributor Whitney Tilson developed a presentation titled "Lessons from a Dozen Years of Short Selling" that he's presented at a handful of investment conferences in New York City. With his permission, we're now...
MBI: 9.24 (+0.06), FCEL: 1.30 (-0.01), HLF: 42.10 (+4.16), AFC: 26.02 (+0.02), VJET: 7.75 (-0.29), LL: 28.51 (-0.84), BLDP: 2.06 (-0.01), NSR: 21.90 (-0.24), TXTR: 26.70 (+0.47), RPTP: 11.86 (+0.14), LNKD: 264.25 (+3.67), ONVO: 4.20 (-0.27), XONE: 13.72 (-0.38), ARNA: 4.80 (-0.21), AGM: 27.99 (+0.06), PLUG: 2.66 (-0.05), FB: 83.80 (+1.05), DDD: 27.61 (+0.12), DECK: 72.06 (+0.17), TRIP: 86.35 (+2.55), CSLT: 8.82 (-0.56), LRN: 16.03 (-0.33), PCLN: 1,179.17 (+2.85), NFLX: 428.30 (+3.09), CROX: 12.08 (+0.15), CALL: 6.99 (+0.08), WRLD: 93.36 (+0.51), SODA: 19.62 (-0.08)

AFC, ISIL Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Thu Sep 25, 3:25AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Allmerica Financial Corp (NYSE:AFC), Intersil Corp (NASDAQ:ISIL) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
AFC: 26.02 (+0.02), ISIL: 15.04 (+0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hims & Hers Health Faces Revenue Challenges and Legal Issues

Updated Category News Views 246

Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...

Continue Reading
Entrée Resources Reports Solid Results for Q3 2025

Updated Category News Views 166

Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...

Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles

Updated Category News Views 10

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Continue Reading
BioLife Solutions Enhances Growth Potential with $73 Million Sale

Updated Category News Views 68

BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...

Continue Reading
Advancements in Universal Vaccine Development by Dx&Vx

Updated Category News Views 154

Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....

Continue Reading